help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-1672
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, L.
Right arrow Articles by Achermann, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, L.
Right arrow Articles by Achermann, J. C.
Right arrowPubmed/NCBI databases
*OMIM
*Genetics Home Reference
Related Collections
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 3 991-999
Copyright © 2007 by The Endocrine Society

Heterozygous Missense Mutations in Steroidogenic Factor 1 (SF1/Ad4BP, NR5A1) Are Associated with 46,XY Disorders of Sex Development with Normal Adrenal Function

Lin Lin, Pascal Philibert, Bruno Ferraz-de-Souza, Daniel Kelberman, Tessa Homfray, Assunta Albanese, Veruska Molini, Neil J. Sebire, Silvia Einaudi, Gerard S. Conway, Ieuan A. Hughes, J. Larry Jameson, Charles Sultan, Mehul T. Dattani and John C. Achermann

UCL Institute of Child Health (L.L., B.F.-d.-S., D.K., M.T.D., J.C.A.) and Department of Medicine (L.L., B.F.S., G.S.C., J.C.A.), University College London, London WC1N 1EH, United Kingdom; Service d’Hormonologie du Développement et de la Reproduction (P.P., C.S.), Hôpital Lapeyronie et Institut National de la Santé et de la Recherche Médicale U540, Centre Hospitalier Universitaire, and Unité d’Endocrinologie Pédiatrique (C.S.), Hôpital Arnaud de Villeneuve, Centre Hospitalier Universitaire Montpellier, 34295 Montpellier, France; Departments of Medical Genetics (T.H.) and Paediatric Endocrinology (A.A.), St. George’s Hospital Medical School, London SW17 0RE, United Kingdom; Department of Paediatric Endocrinology (V.M., S.E.), Regina Margherita Hospital, 10126 Turin, Italy; Department of Paediatric Histopathology (N.J.S.), Great Ormond Street Hospital for Children, London WC1N 1LE, United Kingdom; Department of Paediatrics (I.A.H.), University of Cambridge, Cambridge CB2 1TN, United Kingdom; and Feinberg School of Medicine (J.L.J.), Northwestern University, Chicago, Illinois 60611

Address all correspondence and requests for reprints to: Dr. John C. Achermann, Developmental Endocrinology Research Group, Clinical and Molecular Genetics Unit, UCL Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, United Kingdom. E-mail: j.achermann{at}ich.ucl.ac.uk.

Context: Steroidogenic factor 1 (SF1/AdBP4/FTZF1, NR5A1) is a nuclear receptor transcription factor that plays a key role in regulating adrenal and gonadal development, steroidogenesis, and reproduction. Targeted deletion of Nr5a1 (Sf1) in the mouse results in adrenal and gonadal agenesis, XY sex-reversal, and persistent Müllerian structures in males. Consistent with the murine phenotype, human mutations in SF1 were described initially in two 46,XY individuals with female external genitalia, Müllerian structures (uterus), and primary adrenal failure.

Objective: Given recent case reports of haploinsufficiency of SF1 affecting testicular function in humans, we aimed to identify SF1 mutations in a cohort of individuals with a phenotypic spectrum of 46,XY gonadal dysgenesis/impaired androgenization (now termed 46,XY disorders of sex development) with normal adrenal function.

Methods and Patients: The study included mutational analysis of NR5A1 in 30 individuals with 46,XY disorders of sex development, followed by functional studies of SF1 activity.

Results: Heterozygous missense mutations in NR5A1 were found in four individuals (four of 30, 13%) with this phenotype. These mutations (V15M, M78I, G91S, L437Q) were shown to impair transcriptional activation through abnormal DNA binding (V15M, M78I, G91S), altered subnuclear localization (V15M, M78I), or disruption of the putative ligand-binding pocket (L437Q). Two mutations appeared to be de novo or germline changes. The other two mutations appeared to be inherited in a sex-limited dominant manner because the mother is heterozygous for the change.

Conclusions: These studies demonstrate that SF1 mutations are more frequent than previously suspected causes of impaired fetal and postnatal testicular function in 46,XY individuals.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk
The Mammalian Ovary from Genesis to Revelation
Endocr. Rev., October 1, 2009; 30(6): 624 - 712.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. A. Metherell, D. Naville, G. Halaby, M. Begeot, A. Huebner, G. Nurnberg, P. Nurnberg, J. Green, J. W. Tomlinson, N. P. Krone, et al.
Nonclassic Lipoid Congenital Adrenal Hyperplasia Masquerading as Familial Glucocorticoid Deficiency
J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3865 - 3871.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. Kohler, L. Lin, I. Mazen, C. Cetindag, H. Biebermann, I. Akkurt, R. Rossi, O. Hiort, A. Gruters, and J. C Achermann
The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency
Eur. J. Endocrinol., August 1, 2009; 161(2): 237 - 242.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Lourenco, R. Brauner, L. Lin, A. De Perdigo, G. Weryha, M. Muresan, R. Boudjenah, G. Guerra-Junior, A. T. Maciel-Guerra, J. C. Achermann, et al.
Mutations in NR5A1 Associated with Ovarian Insufficiency
N. Engl. J. Med., March 19, 2009; 360(12): 1200 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. P. Sablin, R. D. Blind, I. N. Krylova, J. G. Ingraham, F. Cai, J. D. Williams, R. J. Fletterick, and H. A. Ingraham
Structure of SF-1 Bound by Different Phospholipids: Evidence for Regulatory Ligands
Mol. Endocrinol., January 1, 2009; 23(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Zubair, K. L. Parker, and K.-i. Morohashi
Developmental Links between the Fetal and Adult Zones of the Adrenal Cortex Revealed by Lineage Tracing
Mol. Cell. Biol., December 1, 2008; 28(23): 7030 - 7040.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Philibert, D. Zenaty, L. Lin, S. Soskin, F. Audran, J. Leger, J. C. Achermann, and C. Sultan
Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study
Hum. Reprod., December 1, 2007; 22(12): 3255 - 3261.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. L Reuter, K. Goji, N. C Bingham, M. Matsuo, and K. L Parker
A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency
Eur. J. Endocrinol., August 1, 2007; 157(2): 233 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Coutant, D. Mallet, N. Lahlou, N. Bouhours-Nouet, A. Guichet, L. Coupris, A. Croue, and Y. Morel
Heterozygous Mutation of Steroidogenic Factor-1 in 46,XY Subjects May Mimic Partial Androgen Insensitivity Syndrome
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2868 - 2873.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society